Showing 481-490 of 839 results for "".
- Ocular Therapeutix Promotes Michael Goldstein, MD, MBA, to President, Ophthalmologyhttps://modernod.com/news/ocular-therapeutix-promotes-michael-goldstein-md-mba-to-president-ophthalmology/2478733/Ocular Therapeutix announced the promotion of Michael Goldstein, MD, MBA, to the newly created position of President, Ophthalmology. Dr. Goldstein will continue to report to Antony Mattessich, Ocular’s President and Chief Executive Officer. With this promotion, Dr. Goldstein will be responsible f
- Neurotech Pharmaceuticals Appoints John Pollack, MD, as Chief Medical Officerhttps://modernod.com/news/neurotech-pharmaceuticals-appoints-john-pollack-md-as-chief-medical-officer/2478549/Neurotech Pharmaceuticals announced that John Pollack, MD, has been appointed to the position of Chief Medical Officer (CMO). Dr. Pollack’s responsibilities will include the execution of clinical studies, patient safety, and the management of Medical Affairs; supporting the required regulatory su
- Oxurion Appoints Grace Chang, MD, PhD, as Chief Medical Officerhttps://modernod.com/news/oxurion-appoints-grace-chang-md-phd-as-chief-medical-officer/2478109/Oxurion NV announced the appointment of Grace Chang, MD, PhD, as the company’s Chief Medical Officer, effective August 1, 2020. Dr. Chang is a board-certified ophthalmologist and practicing vitreoretinal surgeon with deep expertise in ophthalmic drug research and development. She will be r
- Gil Kliman, MD, and Tom Frinzi Appointed to STAAR Surgical Board of Directorshttps://modernod.com/news/gil-kliman-md-and-tom-frinzi-appointed-to-staar-surgical-board-of-directors/2477846/Staar Surgical announced the appointment of Gilbert H. Kliman, MD, Managing Partner, InterWest Partners, and Thomas G. Frinzi, former Worldwide President, Surgical, Johnson & Johnson Vision, to its board of directors, effective June 1, 2020. The appointment of Dr. Kliman and Mr. Frinzi brings
- CXL Ophthalmics Appoints Jonathan H. Talamo, MD, to its Board of Managershttps://modernod.com/news/cxl-ophthalmics-appoints-jonathan-h-talamo-md-to-its-board-of-managers/2477675/CXL Ophthalmics announced the appointment of Jonathan H. Talamo, MD, to its Board of Managers. Dr. Talamo was most recently Chief Medical Officer and Worldwide Vice President of Clinical and Medical Affairs at Johnson and Johnson Vision. While at Johnson and Johnson Vision, Dr. Talamo hel
- Mayo Clinic’s Jonathan Holmes, MD, Appointed UArizona Chair of Ophthalmologyhttps://modernod.com/news/mayo-clinics-jonathan-holmes-md-appointed-uarizona-chair-of-ophthalmology/2477537/Jonathan M. Holmes, MD, has been appointed chair of the University of Arizona College of Medicine – Tucson Department of Ophthalmology, effective Friday, July 31. Dr. Holmes currently serves as the Joseph E. and Rose Marie Green Professor of Visual Sciences and professor of ophthalmology a
- Calvin Roberts, MD, Named President and CEO of Lighthouse Guildhttps://modernod.com/news/calvin-roberts-md-named-president-and-ceo-of-lighthouse-guild/2477286/Calvin Roberts, MD, has been elected President and CEO of Lighthouse Guild. Dr. Roberts will leave his position as Senior Vice President and Chief Medical Officer, Eye Care, at Bausch Health Companies, on March 31. Dr. Roberts i
- Pioneering Ophthalmologist Spencer P. Thornton, MD, Dies at Age 90https://modernod.com/news/pioneering-ophthalmologist-spencer-p-thornton-md-dies-at-age-90/2477074/Spencer P. Thornton, MD, died at age 90 on October 26, 2019. A pioneer in the field of refractive surgery, Dr. Thornton served as the president of the ASCRS from 1997 to 1999 and received the society’s lifetime achievement award earlier this year. He was an internationally recognized speaker and
- Retina Specialist Brett Foxman, MD, Earns U.S. Patent for Scleral Depressorhttps://modernod.com/news/retina-specialist-brett-foxman-md-earns-u-s-patent-for-scleral-depressor/2476788/Brett Foxman, MD, Clinical Service Chief in Ophthalmology at Shore Medical Center in Somers Point, New Jersey, recently won a U.S. patent for his new version of the scleral depressor. Dr. Foxman said after performing thousands of eye surgeries using a tool that had stayed essentially uncha
- Alimera Sciences Appoints Samer Kaba, MD, as Chief Medical Officerhttps://modernod.com/news/alimera-sciences-appoints-samer-kaba-md-as-chief-medical-officer/2476464/Alimera Sciences announced an expansion of its leadership team with the appointment of Samer Kaba, MD, as Chief Medical Officer, effective April 4, 2019. “I am very pleased that Samer will be joining us in this new position as he will bring both a physician’s perspect